Monitoring glucose levels in kidney transplant patients after surgery
Prospective Observational Study for Efficacy of Perioperative Serum Glucose Level Evaluated by Continuous Glucose Monitoring System in Kidney Transplantation Patients
Seoul National University Hospital · NCT06012799
This study is testing how well Continuous Glucose Monitoring can help track blood sugar changes in kidney transplant patients to see if it can predict new diabetes after their surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Seoul National University Hospital (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06012799 on ClinicalTrials.gov |
What this trial studies
This observational study aims to utilize Continuous Glucose Monitoring (CGM) to track glucose fluctuations in kidney transplant recipients and predict the onset of New-Onset Diabetes After Transplantation (NODAT). It will investigate how medications and surgical procedures, particularly immunosuppressants and steroids, affect glucose variability in these patients. By observing these patterns, the study seeks to identify factors that influence blood glucose levels, contributing to improved management strategies for kidney transplant patients in the future.
Who should consider this trial
Good fit: Ideal candidates for this study are kidney transplant recipients aged 18 and older who have undergone the procedure at Seoul National University Hospital since March 2021.
Not a fit: Patients who have had multi-organ transplants or previous kidney transplants will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management of blood glucose levels in kidney transplant recipients, potentially reducing the incidence of diabetes post-transplant.
How similar studies have performed: While continuous glucose monitoring has been used in various contexts, this specific application in kidney transplant patients is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study will target 100 kidney transplant patients who have provided consent, among those who underwent the procedure at Seoul National University Hospital after March 2021. Exclusion Criteria: * multi-organ transplant * history of previous kidney transplant * less than 18 years old
Where this trial is running
Seoul
- Seoul National University Hospital — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Study coordinator: Jiyoung Sin, MD
- Email: taddy11119@gmail.com
- Phone: 82-10-6593-6503
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: New Onset Diabetes After Transplantation